Rituximab for Children With Difficult-to-Treat Nephrotic Syndrome: Its Effects on Disease Progression and Growth

Creative Commons License

TOPALOĞLU R., GÜLHAN B., Celegen K., Inozu M., Hayran M., Duzoya A., ...More

FRONTIERS IN PEDIATRICS, vol.7, 2019 (SCI-Expanded) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 7
  • Publication Date: 2019
  • Doi Number: 10.3389/fped.2019.00313
  • Journal Name: FRONTIERS IN PEDIATRICS
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Keywords: rituximab, nephrotic syndrome, steroid, cyclosporine, growth, MYCOPHENOLATE-MOFETIL, MULTICENTER, SAFETY
  • Hacettepe University Affiliated: Yes

Abstract

Background: Since the early 2000s rituximab (RTX) has been thought of as an alternative treatment for steroid-sensitive nephrotic syndrome (SSNS) and steroid-resistant nephrotic syndrome (SRNS).